ARID1A and medullary thyroid gland carcinoma: Sanger sequencing showed that MTC-22 cells harboured mutations in ARID1A (Q1346*) and PIK3CB (E1051K), both identical to those seen in the patient’s tumour tissue (Fig. 4d).